News

Sanofi reports on first patient outside U.S. treated in global Kevzaraclinical trial program for patients with severe COVID-19

The use of Kevzara to treat the symptoms of COVID-19 is investigational and has not been evaluated by any regulatory authority.

Read More

Apr 01, 2020

By : Team ABLE

Beckman Coulter develops tests to detect coronavirus antibodies

Beckman Coulter has announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.

Read More

Apr 01, 2020

By : Team ABLE

Unicorn India Ventures invests in neo diagnostics startup SaScan

This year, SaScan is focusing on bringing OralScan to the market, a handheld fully automated solution for non-intrusive Oral Cancer screening.

Read More

Apr 01, 2020

By : Team ABLE

IKP launches I-CO Fund to empower & fast track Innovations for COVID-19

IKP plans to fast track 8 solutions for screening, diagnostics and equipment for combating COVID-19

Read More

Mar 31, 2020

By : Team ABLE

Intas donates two million tablets of hydroxychloroquine for global trials against COVID19

Intas Pharmaceuticals has donated up to two million tablets of hydroxychloroquine to enable the largest interventional COVID-19 trial in the world involving up to 40,000 frontline healthcare workers

Read More

Mar 31, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

INDIA PAVILION at BIO-Europe

November 9–11, 2026 | Koelnmesse, Cologne, Germany

Focus Areas

Highlights